Cipla-SIGA Antibacterial Alliance To Tackle Resistance, Biothreats

BARDA Among Customers?

 
• By Anju Ghangurde

Cipla, which has long-standing experience in antibiotic development in India, strikes alliance with US firm SIGA Technologies. The partners are targeting novel antibacterials, especially against biothreats, and expect to cater to US agency BARDA, among others.

Superbug strain bacteria concept as a killer microbe shaped as a death skull face as a symbol for MRSA medical healthcare risk and antimicrobial health hazard as a 3D illustration on white. - Illustration
Cipla-SIGA Partnership To Tackle AMR Public Health Challenge • Source: Shutterstock

More from Business

More from Scrip